It is now widely accepted that inflammation is critical in cardiovascular diseases (CVD).
Here, studies are being conducted on how cyclic GMP-AMP synthase (cGAS), a component …

Cardiovascular diseases (CVDs) encompass a range of disorders, from congenital heart
malformation, cardiac valve, peripheral artery, coronary artery, cardiac muscle diseases, and …

Patients with preexisting cardiovascular disease or those at high risk for developing the
condition are often offered exercise as a form of therapy. Patients with cancer who are at an …

Implementing Single-cell RNA sequencing (scRNA-seq) has significantly enhanced our
comprehension of cardiovascular diseases (CVDs), providing new opportunities to …

Cardiovascular disease is the leading cause of death, medical complications, and
healthcare costs. Although recent advances have been in treating cardiovascular disorders …

Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality
worldwide. Effective prevention and management strategies are essential to reduce the …

Noncoding RNAs (ncRNAs) are pivotal for various pathological processes, impacting
disease progression. The potential for leveraging ncRNAs to prevent or treat atherosclerosis …

Cardiovascular diseases (CVDs) are still leading to a significant number of deaths
worldwide despite the remarkable advancements in medical technology and pharmacology …

Cardiovascular disease, particularly coronary heart disease, is becoming more common
among those living with HIV. Individuals with HIV face an increased susceptibility to …

Cardiovascular diseases (CVDs) are known as life-threatening illnessescaused by severe
abnormalities in the cardiovascular system. They are a leading cause of mortality and …